Skip to main content
Erschienen in: Zeitschrift für Gerontologie und Geriatrie 1/2012

01.01.2012 | Beiträge zum Themenschwerpunkt

Diabetes und Demenz

verfasst von: Dr. A. Bahrmann, P. Bahrmann, T. Kubiak, D. Kopf, P. Oster, C.C. Sieber, W.G. Daniel

Erschienen in: Zeitschrift für Gerontologie und Geriatrie | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Zusammenfassung

Diabetes mellitus ist ein bekannter Risikofaktor für kognitive Störungen und Demenzerkrankungen. Bei der Entwicklung kognitiver Störungen spielen neben der chronischen Hyperglykämie weitere Faktoren wie genetische Prädisposition, arterielle Hypertonie, Hyperlipoproteinämie, mikro- und makrovaskuläre Erkrankungen sowie die Depression eine wichtige Rolle. In der vorliegenden Übersichtsarbeit werden sowohl die pathophysiologische Zusammenhänge zwischen den Erkrankungen Diabetes und Demenz als auch die Besonderheiten der Diabetestherapie bei Demenzerkrankten differenziert dargestellt.
Literatur
1.
Zurück zum Zitat Anderson RJ, Freedland KE, Clouse RE, Lustman PJ (2001) The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24(6):1069–1078PubMedCrossRef Anderson RJ, Freedland KE, Clouse RE, Lustman PJ (2001) The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24(6):1069–1078PubMedCrossRef
2.
Zurück zum Zitat Barrou Z, Lemaire A, Boddaert J, Verny M (2008) Diabetes and cognition – is there a link? Psychol Neuropsychiatr Vieil 3:189–198 Barrou Z, Lemaire A, Boddaert J, Verny M (2008) Diabetes and cognition – is there a link? Psychol Neuropsychiatr Vieil 3:189–198
3.
Zurück zum Zitat Black SA, Markides KS, Ray LA (2003) Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. Diabetes Care 26(10):2822–2828PubMedCrossRef Black SA, Markides KS, Ray LA (2003) Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. Diabetes Care 26(10):2822–2828PubMedCrossRef
4.
Zurück zum Zitat Bruce DG, Davis WA, Casey GP et al (2009) Severe hypoglycaemia and cognitive impairment in older patients with diabetes: the Fremantle Diabetes Study. Diabetologia 52:1808–1815PubMedCrossRef Bruce DG, Davis WA, Casey GP et al (2009) Severe hypoglycaemia and cognitive impairment in older patients with diabetes: the Fremantle Diabetes Study. Diabetologia 52:1808–1815PubMedCrossRef
5.
Zurück zum Zitat Braun A, Müller UA, Muller R et al (2004) Structured treatment and teaching of patients with type 2 diabetes mellitus and impaired cognitive function – the DICOF trial. Diabet Med 21(9):999–1006PubMedCrossRef Braun A, Müller UA, Muller R et al (2004) Structured treatment and teaching of patients with type 2 diabetes mellitus and impaired cognitive function – the DICOF trial. Diabet Med 21(9):999–1006PubMedCrossRef
6.
Zurück zum Zitat Carmelli D, Swan GE, Reed T et al (1999) Midlife cardiovascular risk factors and brain morphology in identical older male twins. Neurology 52:1119–1124PubMed Carmelli D, Swan GE, Reed T et al (1999) Midlife cardiovascular risk factors and brain morphology in identical older male twins. Neurology 52:1119–1124PubMed
7.
Zurück zum Zitat Currie CJ, Peters JR, Tynan A et al (2010) Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. Lancet 375(9713):481–489PubMedCrossRef Currie CJ, Peters JR, Tynan A et al (2010) Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. Lancet 375(9713):481–489PubMedCrossRef
8.
Zurück zum Zitat Ding J, Strachan MW, Reynolds RM et al; Edinburgh Type 2 Diabetes Study Investigators (2010) Diabetic retinopathy and cognitive decline in older people with type 2 diabetes. Diabetes 59(11):2883–2889PubMedCrossRef Ding J, Strachan MW, Reynolds RM et al; Edinburgh Type 2 Diabetes Study Investigators (2010) Diabetic retinopathy and cognitive decline in older people with type 2 diabetes. Diabetes 59(11):2883–2889PubMedCrossRef
9.
Zurück zum Zitat Elias PK, Elias MF, D’Augostino RB et al (1997) NIDDM and blood pressure as risk factors for poor cognitive performance. Diabetes care 20:1388–1395PubMedCrossRef Elias PK, Elias MF, D’Augostino RB et al (1997) NIDDM and blood pressure as risk factors for poor cognitive performance. Diabetes care 20:1388–1395PubMedCrossRef
10.
Zurück zum Zitat Fernandez MM, Castro FJ, Perez HS de las (2008) Risk factors for dementia in the epidemiological study of Munguialde County (Basque Country Spain). BMC Neurology 8:39CrossRef Fernandez MM, Castro FJ, Perez HS de las (2008) Risk factors for dementia in the epidemiological study of Munguialde County (Basque Country Spain). BMC Neurology 8:39CrossRef
11.
Zurück zum Zitat Forette F, Seux ML, Staessen J et al (1998) Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) Trial. Lancet 352:1347–1351PubMedCrossRef Forette F, Seux ML, Staessen J et al (1998) Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) Trial. Lancet 352:1347–1351PubMedCrossRef
12.
Zurück zum Zitat Gonzalez JS, Peyrot M, McCarl LA et al (2008) A depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care 31(12):2398–2403PubMedCrossRef Gonzalez JS, Peyrot M, McCarl LA et al (2008) A depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care 31(12):2398–2403PubMedCrossRef
13.
Zurück zum Zitat Harrington C, Sawchak S, Chiang C et al (2011) Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-moderate Alzheimer’s disease: two phase 3 studies. Curr Alzheimer Res 8(5):592–606PubMedCrossRef Harrington C, Sawchak S, Chiang C et al (2011) Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-moderate Alzheimer’s disease: two phase 3 studies. Curr Alzheimer Res 8(5):592–606PubMedCrossRef
14.
Zurück zum Zitat Hermanns N, Kulzer B, Krichbaum M et al (2005) Affective and anxiety disorders in a German sample of diabetic patients: prevalence, comorbidity and risk factors. Diabet Med 22(3):293–300PubMedCrossRef Hermanns N, Kulzer B, Krichbaum M et al (2005) Affective and anxiety disorders in a German sample of diabetic patients: prevalence, comorbidity and risk factors. Diabet Med 22(3):293–300PubMedCrossRef
15.
Zurück zum Zitat Hsiung GY, Sadovnik AD, Feldman H (2004) Apolipoprotein E epsiolon 4 genotype as risk factor for cognitive decline and dementia: data from the Canadian Study for Health and Ageing. Can Med Assoc J 171:863–867CrossRef Hsiung GY, Sadovnik AD, Feldman H (2004) Apolipoprotein E epsiolon 4 genotype as risk factor for cognitive decline and dementia: data from the Canadian Study for Health and Ageing. Can Med Assoc J 171:863–867CrossRef
16.
Zurück zum Zitat Jorm AF, Jolly D (1998) The incidence of dementia – a meta analysis. Neurology 51(3):728–733PubMed Jorm AF, Jolly D (1998) The incidence of dementia – a meta analysis. Neurology 51(3):728–733PubMed
17.
Zurück zum Zitat Kalmijn S, Foley D, White L et al (2000) Metabolic cardiovascular syndrome and risk of dementia in Japanese- American elderly men. The Honolulu-Asia Aging Study. Arterioscler Thromb Vasc Biol 20:2255–2260PubMedCrossRef Kalmijn S, Foley D, White L et al (2000) Metabolic cardiovascular syndrome and risk of dementia in Japanese- American elderly men. The Honolulu-Asia Aging Study. Arterioscler Thromb Vasc Biol 20:2255–2260PubMedCrossRef
18.
Zurück zum Zitat Katon WJ, Lin EHB, Williams LH et al (2010) Comorbid depression is associated with an increased risk of dementia diagnosis in patients with diabetes: a prospective cohort study. J Gen Intern Med 25(5):423–429PubMedCrossRef Katon WJ, Lin EHB, Williams LH et al (2010) Comorbid depression is associated with an increased risk of dementia diagnosis in patients with diabetes: a prospective cohort study. J Gen Intern Med 25(5):423–429PubMedCrossRef
19.
Zurück zum Zitat Knol MJ, Twisk JWR, Beekman ATF et al (2006) Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia 49(5):837–845PubMedCrossRef Knol MJ, Twisk JWR, Beekman ATF et al (2006) Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia 49(5):837–845PubMedCrossRef
20.
Zurück zum Zitat Kopf D, Frölich M (2009) Risk of incident Alzheimer’s disease in diabetic patients: a systematic review of prospective trials. J Alzheimers Dis 16(4):677–685PubMed Kopf D, Frölich M (2009) Risk of incident Alzheimer’s disease in diabetic patients: a systematic review of prospective trials. J Alzheimers Dis 16(4):677–685PubMed
21.
Zurück zum Zitat Kopf D (2009) Einfluss von Diabetes mellitus, Übergewicht und Bewegungsmangel auf Morbus Alzheimer – Interaktion von Insulin mit Amyloid und phosphoryliertem Tau-Protein. Klinikarzt 38:228–233 Kopf D (2009) Einfluss von Diabetes mellitus, Übergewicht und Bewegungsmangel auf Morbus Alzheimer – Interaktion von Insulin mit Amyloid und phosphoryliertem Tau-Protein. Klinikarzt 38:228–233
22.
Zurück zum Zitat Kulzer B, Albus C, Herpertz S et al (2010) Psychosoziales und Diabetes mellitus. Praxisleitlinie der Deutschen Diabetesgesellschaft 5:139–145 Kulzer B, Albus C, Herpertz S et al (2010) Psychosoziales und Diabetes mellitus. Praxisleitlinie der Deutschen Diabetesgesellschaft 5:139–145
23.
Zurück zum Zitat Leonard BE (2007) Inflammation, depression and dementia: are they connected? Neurochem Res 32(10):1749–1756PubMedCrossRef Leonard BE (2007) Inflammation, depression and dementia: are they connected? Neurochem Res 32(10):1749–1756PubMedCrossRef
24.
Zurück zum Zitat Luchsinger JA, Reitz C, Honig LS et al (2005) Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology 65:545–551PubMedCrossRef Luchsinger JA, Reitz C, Honig LS et al (2005) Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology 65:545–551PubMedCrossRef
25.
Zurück zum Zitat Marioni RE, Strachan MW, Reynolds RM et al (2010) Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes 59:710–713PubMedCrossRef Marioni RE, Strachan MW, Reynolds RM et al (2010) Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes 59:710–713PubMedCrossRef
26.
Zurück zum Zitat Mezuk B, Eaton WW, Albrecht S, Golden SH (2008) Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care 31(12):2383–2390PubMedCrossRef Mezuk B, Eaton WW, Albrecht S, Golden SH (2008) Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care 31(12):2383–2390PubMedCrossRef
27.
Zurück zum Zitat Murray AM, Barzilay JI, Lovato JF et al for the Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes (ACCORD-MIND) Substudy Investigators (2011) Biomarkers of renal function and cognitive impairment in patients with diabetes. Diabetes Care 34(8):1827–1832PubMedCrossRef Murray AM, Barzilay JI, Lovato JF et al for the Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes (ACCORD-MIND) Substudy Investigators (2011) Biomarkers of renal function and cognitive impairment in patients with diabetes. Diabetes Care 34(8):1827–1832PubMedCrossRef
28.
Zurück zum Zitat Ott A, Stolk RP, Hofman A et al (1996) Association of diabetes and dementia. The Rotterdam Study. Diabetologia 39:1392–1397PubMedCrossRef Ott A, Stolk RP, Hofman A et al (1996) Association of diabetes and dementia. The Rotterdam Study. Diabetologia 39:1392–1397PubMedCrossRef
29.
Zurück zum Zitat Pasquier F, Boulogne A, Leys D, Fontaine P (2006) Diabetes mellitus and dementia. Diabetes Metab 32:403–414PubMedCrossRef Pasquier F, Boulogne A, Leys D, Fontaine P (2006) Diabetes mellitus and dementia. Diabetes Metab 32:403–414PubMedCrossRef
30.
Zurück zum Zitat Peila R, Rodriguez BL, Launer LJ; Honolulu-Asia Aging Study Type 2 diabetes (2002), APOE gene, and the risk for dementia and related pathologies. Diabetes 51:1256–1262PubMedCrossRef Peila R, Rodriguez BL, Launer LJ; Honolulu-Asia Aging Study Type 2 diabetes (2002), APOE gene, and the risk for dementia and related pathologies. Diabetes 51:1256–1262PubMedCrossRef
31.
Zurück zum Zitat Reynolds RM, Strachan MW, Labad J et al (2010) Morning cortisol levels and cognitive abilities in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care 33(4):714–720PubMedCrossRef Reynolds RM, Strachan MW, Labad J et al (2010) Morning cortisol levels and cognitive abilities in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care 33(4):714–720PubMedCrossRef
32.
Zurück zum Zitat Riederer P, Bartl J, Laux G, Grünblatt E (2011) Diabetes type II: a risk factor for depression, Parkinson, Alzheimer? Neurotox Res 19(2):253–265PubMedCrossRef Riederer P, Bartl J, Laux G, Grünblatt E (2011) Diabetes type II: a risk factor for depression, Parkinson, Alzheimer? Neurotox Res 19(2):253–265PubMedCrossRef
33.
Zurück zum Zitat Rönnemaa E, Zethelius B, Sundelöf J et al (2008) Impaired insulin secretion increases the risk of Alzheimer disease. Neurology 71:1065–1071PubMedCrossRef Rönnemaa E, Zethelius B, Sundelöf J et al (2008) Impaired insulin secretion increases the risk of Alzheimer disease. Neurology 71:1065–1071PubMedCrossRef
34.
Zurück zum Zitat Rovio S, Kåreholt I, Helkala EL et al (2005) Leisure-time physical activity at midlife and the risk of dementia and Alzheimer’s disease. Lancet Neurol 4(11):705–711PubMedCrossRef Rovio S, Kåreholt I, Helkala EL et al (2005) Leisure-time physical activity at midlife and the risk of dementia and Alzheimer’s disease. Lancet Neurol 4(11):705–711PubMedCrossRef
35.
Zurück zum Zitat Stewart R, Liolitsa D (1999) Type 2 diabetes mellitus, cognitive impairment, and dementia. Diabet Med 16:93–112PubMedCrossRef Stewart R, Liolitsa D (1999) Type 2 diabetes mellitus, cognitive impairment, and dementia. Diabet Med 16:93–112PubMedCrossRef
37.
Zurück zum Zitat Strachan MW, Reynolds RM, Marioni RE, Price JF (2011) Cognitive function, dementia and type 2 diabetes mellitus in the elderly. Nat Rev Endocrinol 7:108–114PubMedCrossRef Strachan MW, Reynolds RM, Marioni RE, Price JF (2011) Cognitive function, dementia and type 2 diabetes mellitus in the elderly. Nat Rev Endocrinol 7:108–114PubMedCrossRef
38.
Zurück zum Zitat Whitmer RA, Karter AJ, Yaffe K et al (2009) Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 301:1565–1572PubMedCrossRef Whitmer RA, Karter AJ, Yaffe K et al (2009) Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 301:1565–1572PubMedCrossRef
39.
Zurück zum Zitat Wörz E, Bahrmann A, Specht-Leible N, Oster P (2010) Struktur- und Behandlungsqualität von geriatrischen Patienten mit Diabetes mellitus im Pflegeheim. Diabetol Stoffwechs 5:66, P196 Wörz E, Bahrmann A, Specht-Leible N, Oster P (2010) Struktur- und Behandlungsqualität von geriatrischen Patienten mit Diabetes mellitus im Pflegeheim. Diabetol Stoffwechs 5:66, P196
40.
Zurück zum Zitat Xu W, Qiu C, Winblad B, Fratiglioni L (2007) The effect of borderline diabetes on the risk of dementia and Alzheimer’s disease. Diabetes 56:211–216PubMedCrossRef Xu W, Qiu C, Winblad B, Fratiglioni L (2007) The effect of borderline diabetes on the risk of dementia and Alzheimer’s disease. Diabetes 56:211–216PubMedCrossRef
41.
Zurück zum Zitat Zeyfang A, Bahrmann A, Wernecke J (2011) Diabetes mellitus im Alter. Praxisleitlinie der Deutschen Diabetesgesellschaft. Diabetol Stoffwechs 6:170–175CrossRef Zeyfang A, Bahrmann A, Wernecke J (2011) Diabetes mellitus im Alter. Praxisleitlinie der Deutschen Diabetesgesellschaft. Diabetol Stoffwechs 6:170–175CrossRef
42.
Zurück zum Zitat Zeyfang A, Dippel W, Bahrmann A et al (2010) Aktuelle Versorgungssituation und Ressourcenbedarf bei insulinpflichtigen Typ-2-Diabetikern in stationärer und ambulanter Pflege: Ergebnisse der LIVE-GERI-Studie. Diabetol Stoffwechs 5:293–300CrossRef Zeyfang A, Dippel W, Bahrmann A et al (2010) Aktuelle Versorgungssituation und Ressourcenbedarf bei insulinpflichtigen Typ-2-Diabetikern in stationärer und ambulanter Pflege: Ergebnisse der LIVE-GERI-Studie. Diabetol Stoffwechs 5:293–300CrossRef
43.
Zurück zum Zitat Zuccala G, Pedone C, Cesari M et al (2003) The effects of cognitive impairment on mortality among hospitalized patients with heart failure. Am J Med 115:97–103PubMedCrossRef Zuccala G, Pedone C, Cesari M et al (2003) The effects of cognitive impairment on mortality among hospitalized patients with heart failure. Am J Med 115:97–103PubMedCrossRef
44.
Zurück zum Zitat Zuccala G, Onder G, Pedone C et al (2001) Cognitive dysfunction as a major determinant of disability in patients with heart failure: results from a multicenter survey. J Neurol Neurosurg Psychiatry 70:109–112PubMedCrossRef Zuccala G, Onder G, Pedone C et al (2001) Cognitive dysfunction as a major determinant of disability in patients with heart failure: results from a multicenter survey. J Neurol Neurosurg Psychiatry 70:109–112PubMedCrossRef
45.
Zurück zum Zitat Zuccala G, Onder G, Marzetti E et al (2005) Use of angiotensin-converting enzyme inhibitors and variations in cognitive performance among patients with heart failure. Eur Heart J 26:226–233PubMedCrossRef Zuccala G, Onder G, Marzetti E et al (2005) Use of angiotensin-converting enzyme inhibitors and variations in cognitive performance among patients with heart failure. Eur Heart J 26:226–233PubMedCrossRef
Metadaten
Titel
Diabetes und Demenz
verfasst von
Dr. A. Bahrmann
P. Bahrmann
T. Kubiak
D. Kopf
P. Oster
C.C. Sieber
W.G. Daniel
Publikationsdatum
01.01.2012
Verlag
Springer-Verlag
Erschienen in
Zeitschrift für Gerontologie und Geriatrie / Ausgabe 1/2012
Print ISSN: 0948-6704
Elektronische ISSN: 1435-1269
DOI
https://doi.org/10.1007/s00391-011-0269-z

Weitere Artikel der Ausgabe 1/2012

Zeitschrift für Gerontologie und Geriatrie 1/2012 Zur Ausgabe

Medien

Medien

Journal Club

Journal Club

Beiträge zum Themenschwerpunkt

Palliativversorgung von Menschen mit Demenz